L. Données, IRM cardiaque mettent en évidence : ? Une corrélation forte (r=0,77) entre le débit systémique à l'IRM et la

G. Simonneau, I. Robbins, and M. Beghetti, Updated Clinical Classification of Pulmonary Hypertension, Journal of the American College of Cardiology, vol.54, issue.1, pp.43-54, 2009.
DOI : 10.1016/j.jacc.2009.04.012

G. Simonneau, N. Galie, L. Rubin, D. Langleben, W. Seeger et al., Clinical classification of pulmonary hypertension, Journal of the American College of Cardiology, vol.43, issue.12, pp.5-12, 2004.
DOI : 10.1016/j.jacc.2004.02.037

M. Fartoukh, M. Humbert, F. Capron, S. Maitre, F. Parent et al., Severe Pulmonary Hypertension in Histiocytosis X, American Journal of Respiratory and Critical Care Medicine, vol.66, issue.1, pp.216-239, 2000.
DOI : 10.1056/NEJM199701093360207

N. Galiè, M. M. Hoeper, M. Humbert, A. Torbicki, J. Vachiery et al., Guidelines for the diagnosis and treatment of pulmonary hypertension, Revista Portuguesa de Cardiologia (English Edition), vol.31, issue.1, pp.219-1263, 2009.
DOI : 10.1016/j.repce.2011.10.006

P. Herve, J. Launay, M. Scrobohaci, F. Brenot, G. Simonneau et al., Increased plasma serotonin in primary pulmonary hypertension, The American Journal of Medicine, vol.99, issue.3, pp.249-54, 1995.
DOI : 10.1016/S0002-9343(99)80156-9

S. Eddahibi, M. Humbert, E. Fadel, B. Raffestin, M. Darmon et al., Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension, Journal of Clinical Investigation, vol.108, issue.8, pp.1141-50, 2001.
DOI : 10.1172/JCI200112805

S. Eddahibi, A. Chaouat, N. Morrell, E. Fadel, C. Fuhrman et al., Polymorphism of the Serotonin Transporter Gene and Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease, Circulation, vol.108, issue.15, pp.1839-1883, 2003.
DOI : 10.1161/01.CIR.0000091409.53101.E8

K. Lane, R. Machado, M. Pauciulo, J. Thomson, J. Phillips et al., Heterozygous germline mutations in a TGF-beta receptor, BMPR2, are the cause of familial primary pulmonary hypertension, Nat Genet, vol.26, pp.81-85, 2000.

Z. Deng, J. Morse, S. Slager, N. Cuervo, K. Moore et al., Familial Primary Pulmonary Hypertension (Gene PPH1) Is Caused by Mutations in the Bone Morphogenetic Protein Receptor???II Gene, The American Journal of Human Genetics, vol.67, issue.3, pp.737-781, 2000.
DOI : 10.1086/303059

M. Humbert, Z. Deng, G. Simonneau, R. Barst, O. Sitbon et al., BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives, European Respiratory Journal, vol.20, issue.3, pp.518-541, 2002.
DOI : 10.1183/09031936.02.01762002

N. Morrell, X. Yang, P. Upton, K. Jourdan, N. Morgan et al., Altered Growth Responses of Pulmonary Artery Smooth Muscle Cells From Patients With Primary Pulmonary Hypertension to Transforming Growth Factor-??1 and Bone Morphogenetic Proteins, Circulation, vol.104, issue.7, pp.790-795, 2001.
DOI : 10.1161/hc3201.094152

P. Dorfmuller, F. Perros, K. Balabanian, and M. Humbert, Inflammation in pulmonary arterial hypertension, European Respiratory Journal, vol.22, issue.2, pp.358-63, 2003.
DOI : 10.1183/09031936.03.00038903

L. Rubin, Primary Pulmonary Hypertension, New England Journal of Medicine, vol.336, issue.2, pp.111-118, 1997.
DOI : 10.1056/NEJM199701093360207

J. Runo and J. Loyd, Primary pulmonary hypertension, The Lancet, vol.361, issue.9368, pp.1533-1577, 2003.
DOI : 10.1016/S0140-6736(03)13167-4

O. Sitbon, M. Humbert, J. Jagot, O. Taravella, M. Fartoukh et al., Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension, European Respiratory Journal, vol.12, issue.2, pp.265-70, 1998.
DOI : 10.1183/09031936.98.12020265

S. Rich, K. Kieras, K. Hart, B. Groves, J. Stobo et al., Antinuclear antibodies in primary pulmonary hypertension, Journal of the American College of Cardiology, vol.8, issue.6, pp.1307-1318, 1986.
DOI : 10.1016/S0735-1097(86)80301-1

S. Miyamoto, N. Nagaya, T. Satoh, S. Kyotani, F. Sakamaki et al., Clinical Correlates and Prognostic Significance of Six-minute Walk Test in Patients with Primary Pulmonary Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.132, issue.2, pp.487-92, 2000.
DOI : 10.1161/01.CIR.89.4.1733

G. Paciocco, F. Martinez, E. Bossone, E. Pielsticker, B. Gillespie et al., Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension, European Respiratory Journal, vol.17, issue.4, pp.647-52, 2001.
DOI : 10.1183/09031936.01.17406470

N. Nagaya, T. Nishikimi, M. Uematsu, T. Satoh, S. Kyotani et al., Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension, Circulation, vol.102, issue.8, pp.865-70, 2000.
DOI : 10.1161/01.CIR.102.8.865

C. Rubens, R. Ewert, M. Halank, R. Wensel, H. Orzechowski et al., Big Endothelin-1 and Endothelin-1 Plasma Levels Are Correlated With the Severity of Primary Pulmonary Hypertension, Chest, vol.120, issue.5, pp.1562-1571, 2001.
DOI : 10.1378/chest.120.5.1562

N. Nagaya, M. Uematsu, T. Satoh, S. Kyotani, F. Sakamaki et al., Serum Uric Acid Levels Correlate with the Severity and the Mortality of Primary Pulmonary Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.39, issue.2, pp.487-92, 1999.
DOI : 10.1056/NEJM197906283002604

A. Torbicki, M. Kurzyna, P. Kuca, A. Fijalkowska, J. Sikora et al., Detectable Serum Cardiac Troponin T as a Marker of Poor Prognosis Among Patients With Chronic Precapillary Pulmonary Hypertension, Circulation, vol.108, issue.7, pp.844-852, 2003.
DOI : 10.1161/01.CIR.0000084544.54513.E2

V. Fuster, P. Steele, W. Edwards, B. Gersh, M. Mcgoon et al., Primary pulmonary hypertension: natural history and the importance of thrombosis, Circulation, vol.70, issue.4, pp.580-587, 1984.
DOI : 10.1161/01.CIR.70.4.580

J. Bjornsson and W. Edwards, Primary Pulmonary Hypertension: A Histopathologic Study of 80 Cases, Mayo Clinic Proceedings, vol.60, issue.1, pp.16-25, 1985.
DOI : 10.1016/S0025-6196(12)65277-X

M. Humbert, H. Nunes, O. Sitbon, F. Parent, P. Hervé et al., RISK FACTORS FOR PULMONARY ARTERIAL HYPERTENSION, Clinics in Chest Medicine, vol.22, issue.3, pp.459-75, 2001.
DOI : 10.1016/S0272-5231(05)70284-7

O. Sitbon, M. Humbert, X. Jais, V. Ioos, A. M. Hamid et al., Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension, Circulation, vol.111, issue.23, pp.3105-3111, 2005.
DOI : 10.1161/CIRCULATIONAHA.104.488486

R. J. Barst, L. J. Rubin, W. A. Long, M. D. Mcgoon, S. Rich et al., A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension, New England Journal of Medicine, vol.334, issue.5, pp.296-302, 1996.
DOI : 10.1056/NEJM199602013340504

O. Sitbon, M. Humbert, H. Nunes, F. Parent, G. Garcia et al., Long-term intravenous epoprostenol infusion in primary pulmonary hypertension, Journal of the American College of Cardiology, vol.40, issue.4, pp.780-788, 2002.
DOI : 10.1016/S0735-1097(02)02012-0

V. Mclaughlin, A. Shillington, and S. Rich, Survival in Primary Pulmonary Hypertension, Circulation, vol.106, issue.12, pp.1477-1482, 2002.
DOI : 10.1161/01.CIR.0000029100.82385.58

D. Montani, X. Jais, L. C. Price, L. Achouh, B. Degano et al., Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive disease, European Respiratory Journal, vol.34, issue.6, pp.1348-1356, 2009.
DOI : 10.1183/09031936.00017809

G. Simonneau, R. J. Barst, N. Galie, R. Naeije, S. Rich et al., Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.1, issue.6, pp.800-804, 2002.
DOI : 10.7326/0003-4819-115-5-343

H. Olschewski, G. Simonneau, N. Galiè, T. Higenbottam, R. Naeije et al., Inhaled Iloprost for Severe Pulmonary Hypertension, New England Journal of Medicine, vol.347, issue.5, pp.322-329, 2002.
DOI : 10.1056/NEJMoa020204

URL : http://www.nejm.org/doi/pdf/10.1056/NEJMoa020204

R. N. Channick, G. Simonneau, O. Sitbon, I. M. Robbins, A. Frost et al., Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study, The Lancet, vol.358, issue.9288, pp.1119-1123, 2001.
DOI : 10.1016/S0140-6736(01)06250-X

N. Galie, M. Beghetti, M. A. Gatzoulis, J. Granton, R. M. Berger et al., Bosentan Therapy in Patients With Eisenmenger Syndrome: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study, Circulation, vol.114, issue.1, pp.48-54, 2006.
DOI : 10.1161/CIRCULATIONAHA.106.630715

N. Galie, L. Rubin, M. Hoeper, P. Jansa, H. Al-hiti et al., Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial, The Lancet, vol.371, issue.9630, pp.2093-2100, 2008.
DOI : 10.1016/S0140-6736(08)60919-8

M. Humbert, R. J. Barst, I. M. Robbins, R. N. Channick, N. Galie et al., Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2, European Respiratory Journal, vol.24, issue.3, pp.353-359, 2004.
DOI : 10.1183/09031936.04.00028404

L. J. Rubin, D. B. Badesch, R. J. Barst, N. Galie, C. M. Black et al., Bosentan Therapy for Pulmonary Arterial Hypertension, New England Journal of Medicine, vol.346, issue.12, pp.896-903, 2002.
DOI : 10.1056/NEJMoa012212

N. Galie, M. M. Hoeper, M. Humbert, A. Torbicki, J. L. Vachiery et al., Guidelines for the diagnosis and treatment of pulmonary hypertension. The task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the, ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT), pp.1219-1263, 2009.

M. Humbert, E. S. Segal, D. G. Kiely, J. Carlsen, B. Schwierin et al., Results of European post-marketing surveillance of bosentan in pulmonary hypertension, European Respiratory Journal, vol.30, issue.2, pp.338-344, 2007.
DOI : 10.1183/09031936.00138706

R. J. Barst, D. Langleben, D. Badesch, A. Frost, E. C. Lawrence et al., Treatment of Pulmonary Arterial Hypertension With the Selective Endothelin-A Receptor Antagonist Sitaxsentan, Journal of the American College of Cardiology, vol.47, issue.10, pp.2049-2056, 2006.
DOI : 10.1016/j.jacc.2006.01.057

R. J. Barst, D. Langleben, A. Frost, E. M. Horn, R. Oudiz et al., Sitaxsentan Therapy for Pulmonary Arterial Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.169, issue.4, pp.441-447, 2004.
DOI : 10.1016/0021-9681(85)90035-9

N. Galie, H. Olschewski, R. J. Oudiz, F. Torres, A. Frost et al., Ambrisentan for the Treatment of Pulmonary Arterial Hypertension: Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) Study 1 and 2, Circulation, vol.117, issue.23, pp.3010-3019, 2008.
DOI : 10.1161/CIRCULATIONAHA.107.742510

N. Galie, H. A. Ghofrani, A. Torbicki, R. J. Barst, L. J. Rubin et al., Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension, New England Journal of Medicine, vol.353, issue.20, pp.2148-2157, 2005.
DOI : 10.1056/NEJMoa050010

N. Galie, B. H. Brundage, H. A. Ghofrani, R. J. Oudiz, G. Simonneau et al., Tadalafil Therapy for Pulmonary Arterial Hypertension, Circulation, vol.119, issue.22, pp.2894-2903, 2009.
DOI : 10.1161/CIRCULATIONAHA.108.839274

M. Humbert, O. Sitbon, and G. Simonneau, Treatment of Pulmonary Arterial Hypertension, New England Journal of Medicine, vol.351, issue.14, pp.1425-1436, 2004.
DOI : 10.1056/NEJMra040291

URL : https://hal.archives-ouvertes.fr/hal-01455600

V. V. Mclaughlin, R. J. Oudiz, A. Frost, V. F. Tapson, S. Murali et al., Randomized Study of Adding Inhaled Iloprost to Existing Bosentan in Pulmonary Arterial Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.174, issue.11, pp.1257-1263, 2006.
DOI : 10.1183/09031936.04.00051104

G. Simonneau, L. J. Rubin, N. Galie, R. J. Barst, T. R. Fleming et al., Addition of Sildenafil to Long-Term Intravenous Epoprostenol Therapy in Patients with Pulmonary Arterial Hypertension, Annals of Internal Medicine, vol.149, issue.8, pp.521-530, 2008.
DOI : 10.7326/0003-4819-149-8-200810210-00004

D. Doyon, E. Cabanis, B. Roger, J. Frija, and D. Pariente, Idy-Peretti I. Imagerie par résonance magnétique, 2004.

L. Mclure and A. Peacock, Cardiac magnetic resonance imaging for the assessment of the heart and pulmonary circulation in pulmonary hypertension, European Respiratory Journal, vol.33, issue.6, pp.1454-1466, 2009.
DOI : 10.1183/09031936.00139907

D. Pennell, D. Sechtem, U. Higgins, C. Manning, W. Pohost et al., Clinical Indications for Cardiovascular Magnetic Resonance (CMR): Consensus Panel Report #, Journal of Cardiovascular Magnetic Resonance, vol.6, issue.4, pp.727-65, 2004.
DOI : 10.1081/JCMR-200038581

F. Grothues, G. Smith, and J. Moon, Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy, The American Journal of Cardiology, vol.90, issue.1, pp.29-34, 2002.
DOI : 10.1016/S0002-9149(02)02381-0

R. Semelka, E. Tomei, and S. Wagner, Normal left ventricular dimensions and function: interstudy reproducibility of measurements with cine MR imaging., Radiology, vol.174, issue.3, pp.763-768, 1990.
DOI : 10.1148/radiology.174.3.2305059

F. Grothues, J. Moon, and N. Bellenger, Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance, American Heart Journal, vol.147, issue.2, pp.218-223, 2004.
DOI : 10.1016/j.ahj.2003.10.005

M. Robertson, U. Kohler, and P. Hoskins, Quantitative analysis of PC MRI velocity maps: pulsatile flow in cylindrical vessels, Magnetic Resonance Imaging, vol.19, issue.5, pp.685-695, 2001.
DOI : 10.1016/S0730-725X(01)00376-9

H. Uematsu, Y. Ohno, and H. Hatabu, Recent Advances in Magnetic Resonance Perfusion Imaging of the Lung, Topics in Magnetic Resonance Imaging, vol.14, issue.3, pp.245-251, 2003.
DOI : 10.1097/00002142-200306000-00005

M. Hoeper, J. Tongers, and A. Leppert, Evaluation of Right Ventricular Performance With a Right Ventricular Ejection Fraction Thermodilution Catheter and MRI in Patients With Pulmonary Hypertension, Chest, vol.120, issue.2, pp.502-507, 2001.
DOI : 10.1378/chest.120.2.502

S. Arcasoy, J. Christie, and V. Ferrari, Echocardiographic Assessment of Pulmonary Hypertension in Patients with Advanced Lung Disease, American Journal of Respiratory and Critical Care Medicine, vol.167, issue.5, pp.735-740, 2003.
DOI : 10.1164/rccm.2107027

C. Denton, J. Cailes, and G. Phillips, Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis, Rheumatology, vol.36, issue.2, pp.239-243, 1997.
DOI : 10.1093/rheumatology/36.2.239

P. Fedullo, W. Auger, and K. Kerr, Chronic Thromboembolic Pulmonary Hypertension, New England Journal of Medicine, vol.345, issue.20, pp.1465-1472, 2001.
DOI : 10.1056/NEJMra010902

M. Hoeper, S. Lee, and R. Voswinckel, Complications of Right Heart Catheterization Procedures in Patients With Pulmonary Hypertension in Experienced Centers, Journal of the American College of Cardiology, vol.48, issue.12, pp.2546-2552, 2006.
DOI : 10.1016/j.jacc.2006.07.061

V. Noordegraaf, A. Marcus, J. Roseboom, and B. , The Effect of Right Ventricular Hypertrophy on Left Ventricular Ejection Fraction in Pulmonary Emphysema, Chest, vol.112, issue.3, pp.640-645, 1997.
DOI : 10.1378/chest.112.3.640

S. Van-wolferen, J. Marcus, and A. Boonstra, Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension, European Heart Journal, vol.28, issue.10, pp.1250-1257, 2007.
DOI : 10.1093/eurheartj/ehl477

C. Gan, J. Lankhaar, and J. Marcus, Impaired left ventricular filling due to right-to-left ventricular interaction in patients with pulmonary arterial hypertension, Am J Physiol Heart Circ Physiol, vol.290, pp.1528-1533, 2006.

J. Katz, J. Whang, and L. Boxt, Estimation of right ventricular mass in normal subjects and in patients with primary pulmonary hypertension by nuclear magnetic resonance imaging, Journal of the American College of Cardiology, vol.21, issue.6, pp.1475-1481, 1993.
DOI : 10.1016/0735-1097(93)90327-W

R. Roeleveld, J. Marcus, and T. Faes, Interventricular Septal Configuration at MR Imaging and Pulmonary Arterial Pressure in Pulmonary Hypertension, Radiology, vol.234, issue.3, pp.710-717, 2005.
DOI : 10.1148/radiol.2343040151

G. Mccann, C. Gan, and A. Beek, Extent of MRI Delayed Enhancement of Myocardial Mass Is Related to Right Ventricular Dysfunction in Pulmonary Artery Hypertension, American Journal of Roentgenology, vol.188, issue.2, pp.349-355, 2007.
DOI : 10.2214/AJR.05.1259

H. Bogren, R. Klipstein, and R. Mohiaddin, Pulmonary artery distensibility and blood flow patterns: A magnetic resonance study of normal subjects and of patients with pulmonary arterial hypertension, American Heart Journal, vol.118, issue.5, pp.990-999, 1989.
DOI : 10.1016/0002-8703(89)90235-4

C. Kondo, G. Caputo, and T. Masui, Pulmonary hypertension: pulmonary flow quantification and flow profile analysis with velocity-encoded cine MR imaging., Radiology, vol.183, issue.3, pp.751-758, 1992.
DOI : 10.1148/radiology.183.3.1584932

E. Mousseaux, J. Tasu, and O. Jolivet, Pulmonary Arterial Resistance: Noninvasive Measurement with Indexes of Pulmonary Flow Estimated at Velocity-encoded MR Imaging???Preliminary Experience, Radiology, vol.212, issue.3, pp.896-902, 1999.
DOI : 10.1148/radiology.212.3.r99au21896

H. Bogren, R. Klipstein, and R. Mohiaddin, Pulmonary artery distensibility and blood flow patterns: A magnetic resonance study of normal subjects and of patients with pulmonary arterial hypertension, American Heart Journal, vol.118, issue.5, pp.990-999, 1989.
DOI : 10.1016/0002-8703(89)90235-4

C. Jardim, C. Rochitte, and M. Humbert, Pulmonary artery distensibility in pulmonary arterial hypertension: an MRI pilot study, European Respiratory Journal, vol.29, issue.3, pp.476-481, 2007.
DOI : 10.1183/09031936.00016806

C. Gan, J. Lankhaar, and N. Westerhof, Noninvasively Assessed Pulmonary Artery Stiffness Predicts Mortality in Pulmonary Arterial Hypertension, Chest, vol.132, issue.6, pp.1906-1912, 2007.
DOI : 10.1378/chest.07-1246

A. Bouchard, C. Higgins, and B. Byrd, Magnetic resonance imaging in pulmonary arterial hypertension, The American Journal of Cardiology, vol.56, issue.15, pp.938-942, 1985.
DOI : 10.1016/0002-9149(85)90408-4

H. Saito, T. Dambara, and M. Aiba, Evaluation of Cor Pulmonale on a Modified Short-axis Section of the Heart by Magnetic Resonance Imaging, American Review of Respiratory Disease, vol.18, issue.6, pp.1576-1581, 1992.
DOI : 10.1161/01.CIR.56.2.278

A. Torbicki, Cardiac magnetic resonance in pulmonary arterial hypertension: a step in the right direction, European Heart Journal, vol.28, issue.10, pp.49-54, 2009.
DOI : 10.1093/eurheartj/ehm074

G. Simonneau, N. Galie, and L. Rubin, Clinical classification of pulmonary hypertension, Journal of the American College of Cardiology, vol.43, issue.12, pp.5-12, 2004.
DOI : 10.1016/j.jacc.2004.02.037

F. Chabot, F. Schrijen, and F. Poincelot, Interpretation of High Wedge Pressure on Exercise in Patients with Chronic Obstructive Pulmonary Disease, Cardiology, vol.95, issue.3, pp.139-145, 2001.
DOI : 10.1159/000047360

M. Humbert, O. Sitbon, and A. Chaouat, Pulmonary Arterial Hypertension in France, American Journal of Respiratory and Critical Care Medicine, vol.173, issue.9, pp.1023-1030, 2006.
DOI : 10.1183/09031936.04.00010904

A. Tardivon, E. Mousseaux, and F. Brenot, Quantification of hemodynamics in primary pulmonary hypertension with magnetic resonance imaging., American Journal of Respiratory and Critical Care Medicine, vol.150, issue.4, pp.1075-1080, 1994.
DOI : 10.1164/ajrccm.150.4.7921439

D. Alonzo, G. Barst, R. Ayres, and S. , Survival in Patients with Primary Pulmonary Hypertension, Annals of Internal Medicine, vol.115, issue.5, pp.343-349, 1991.
DOI : 10.7326/0003-4819-115-5-343

G. Marrone, G. Mamone, A. Luca, P. Vitulo, A. Bertani et al., The role of 1.5T cardiac MRI in the diagnosis, prognosis and management of pulmonary arterial hypertension, The International Journal of Cardiovascular Imaging, vol.132, issue.6, 2010.
DOI : 10.1016/j.jacc.2008.01.024